BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4870255)

  • 21. [Morphological aspects of the association of triperidol and thioridazine. (Histological experimental study)].
    Pastena L; Ranzato FP
    Riv Neurobiol; 1968; 14(4):632-43. PubMed ID: 5738412
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of triperidol on glucose and pyruvic acid metabolism in rat cerebral cortex slices].
    Gatti G; Michalek H; Pocchiari F
    Ann Ist Super Sanita; 1966; 2(2):277-86. PubMed ID: 6005037
    [No Abstract]   [Full Text] [Related]  

  • 24. [Radioprotective properties of butyrophenone derivatives].
    Uray Z; Farcasanu M; Maniu M
    Agressologie; 1970; 11(4):357-60. PubMed ID: 5485665
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
    Tetreault L; Filotto J; Bordeleau JM
    Can Psychiatr Assoc J; 1968 Dec; 13(6):507-12. PubMed ID: 5726835
    [No Abstract]   [Full Text] [Related]  

  • 26. Sympatholytic treatment of "paralytic" ileus.
    Petri G; Szenohradszky J; Porszasz-Gibiszer K
    Surgery; 1971 Sep; 70(3):359-67. PubMed ID: 5568520
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacologic and clinical properties of a new butyrophenone derivative (FR 33)].
    Kuhn R; Taeschler M; Schoch J
    Psychopharmacologia; 1966; 9(4):351-62. PubMed ID: 4871475
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of two butyrophenones with trifluoperazine.
    Marjerrison G; Hrychuk W; Varsanyi EI
    Can Psychiatr Assoc J; 1966 Feb; 11(1):26-30. PubMed ID: 5322990
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of triperidol on carbohydrate and amino acid metabolism in rat brain-cortex slices.
    Michalek H; Gatti GL; Pocchiari F
    Biochem J; 1968 Nov; 110(2):237-41. PubMed ID: 5726203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trifluperidol and trifluoperazine in acute schizophrenic patients.
    Sugerman AA; Williams BH
    J New Drugs; 1965; 5(5):318-26. PubMed ID: 5329635
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of triperidol].
    Cwynar S; Pionkowski J; Tomczak W; Tyszka E
    Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
    [No Abstract]   [Full Text] [Related]  

  • 33. [Palatoschisis induced by trifluperidol in mice].
    Vichi F; Pierleoni P; Orlando S; Tollaro I
    Sperimentale; 1968; 118(4):245-51. PubMed ID: 5740872
    [No Abstract]   [Full Text] [Related]  

  • 34. [Central and peripheral secondary effects of some butyrophenones].
    Salvini L; Frosali L; Gigli M
    Minerva Anestesiol; 1969 Apr; 35(4):334-44. PubMed ID: 5789993
    [No Abstract]   [Full Text] [Related]  

  • 35. Further observations on trifluperidol: a butyrophenone derivative.
    Gallant DM; Bishop MP; Nesselhof WM; Sprehe DJ
    Psychopharmacologia; 1965 Jan; 7(1):37-43. PubMed ID: 5318922
    [No Abstract]   [Full Text] [Related]  

  • 36. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
    Menon MS; Ramachandran V
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
    [No Abstract]   [Full Text] [Related]  

  • 37. [The blood pressure lowering effect of chlorpromazine and methylperon (Buronil)].
    Magner O; Moller S
    Ugeskr Laeger; 1974 Apr; 136(15):809-11. PubMed ID: 4597391
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
    Sathanathan GL; Angrist BM; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of the central muscle relaxant activity of butyrophenones.
    Rastogi SK; Sinha JN; Bhargava KP
    Jpn J Pharmacol; 1974 Feb; 24(1):163-4. PubMed ID: 4545937
    [No Abstract]   [Full Text] [Related]  

  • 40. On the distribution and metabolism of neuroleptic drugs. 3. Pharmacokinetics of trifluperidol.
    Lewi PJ; Heykants JJ; Janssen PA
    Arzneimittelforschung; 1970 Nov; 20(11):1701-5. PubMed ID: 5536974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.